In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

The updated label no longer requires Leqvio (inclisiran) to be used in combination with statins for low-density lipoprotein ...

Switzerland, home to some the world's most recognisable luxury brands, now faces an upcoming 39 per cent tariff from the US ...

Leqvio can now be used alone, without addition of statin therapy, as adjunct to diet and exercise for LDL-C reduction in patients with hypercholesterolemia (high ...

Novartis announced the FDA approved updated labeling for inclisiran, a small-interfering RNA therapy, for use as monotherapy ...

Switzerland’s exporters, from watch makers to pharmaceutical companies, are bracing for the financial fallout from US ...

In a market note on Wednesday, Scotiabank increased its price target for Apellis Pharmaceuticals, Inc.’s (NASDAQ:APLS) stock ...

The update was requested by the FDA based on data supporting the significant LDL-C lowering abilities of PCSK-targeting therapies.

While the Trump administration tries to pressure drug companies to lower prices, it has also spent months threatening tariffs ...

Experts are skeptical that Big Pharma companies will cut prices after President Donald Trump demands Most Favored Nation policies within 60 days.

President Trump sent letters to major drug companies, urging them to lower U.S. medicine prices to match international rates.